<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

Henschke Responds To Questions from The New York Times

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

Raymond Weiss Reviews Confidential Report on I-ELCAP

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

Study Validates “PEM” Scans As Biopsy Guidance Method

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk

Acupuncture Can Relieve Side Effects of Hormone Treatment

Selumetinib Displays Positive Results, 60% with Stable Disease

National Health Organizations Warn of Risks in Indoor Tanning